Literature DB >> 25857553

Quantifying progression and regression of thrombotic risk in experimental atherosclerosis.

Rohun U Palekar1, Andrew P Jallouk1, Matthew J Goette1, Junjie Chen1, Jacob W Myerson1, John S Allen1, Antonina Akk1, Lihua Yang1, Yizheng Tu1, Mark J Miller1, Christine T N Pham1, Samuel A Wickline2, Hua Pan2.   

Abstract

Currently, there are no generally applicable noninvasive methods for defining the relationship between atherosclerotic vascular damage and risk of focal thrombosis. Herein, we demonstrate methods to delineate the progression and regression of vascular damage in response to an atherogenic diet by quantifying the in vivo accumulation of semipermeable 200-300 nm perfluorocarbon core nanoparticles (PFC-NP) in ApoE null mouse plaques with [(19)F] magnetic resonance spectroscopy (MRS). Permeability to PFC-NP remained minimal until 12 weeks on diet, then increased rapidly following 12 weeks, but regressed to baseline within 8 weeks after diet normalization. Markedly accelerated clotting (53.3% decrease in clotting time) was observed in carotid artery preparations of fat-fed mice subjected to photochemical injury as defined by the time to flow cessation. For all mice on and off diet, an inverse linear relationship was observed between the permeability to PFC-NP and accelerated thrombosis (P = 0.02). Translational feasibility for quantifying plaque permeability and vascular damage in vivo was demonstrated with clinical 3 T MRI of PFC-NP accumulating in plaques of atherosclerotic rabbits. These observations suggest that excessive permeability to PFC-NP may indicate prothrombotic risk in damaged atherosclerotic vasculature, which resolves within weeks after dietary therapy. © FASEB.

Entities:  

Keywords:  MRI; endothelium; nanoparticles; thrombosis

Mesh:

Substances:

Year:  2015        PMID: 25857553      PMCID: PMC4478795          DOI: 10.1096/fj.14-269084

Source DB:  PubMed          Journal:  FASEB J        ISSN: 0892-6638            Impact factor:   5.191


  37 in total

1.  Chapter 16. Two-photon microscopy and multidimensional analysis of cell dynamics.

Authors:  Bernd H Zinselmeyer; John Dempster; David L Wokosin; Jonathan J Cannon; Robert Pless; Ian Parker; Mark J Miller
Journal:  Methods Enzymol       Date:  2009       Impact factor: 1.600

2.  Powerful inflammatory properties of large vein endothelium in vivo.

Authors:  Einar E Eriksson; Eva Karlof; Karin Lundmark; Pierre Rotzius; Ulf Hedin; Xun Xie
Journal:  Arterioscler Thromb Vasc Biol       Date:  2005-01-27       Impact factor: 8.311

Review 3.  Endothelial dysfunction: a marker of atherosclerotic risk.

Authors:  Piero O Bonetti; Lilach O Lerman; Amir Lerman
Journal:  Arterioscler Thromb Vasc Biol       Date:  2003-02-01       Impact factor: 8.311

Review 4.  Intertwining of thrombosis and inflammation in atherosclerosis.

Authors:  Kevin Croce; Peter Libby
Journal:  Curr Opin Hematol       Date:  2007-01       Impact factor: 3.284

5.  Simultaneous dual frequency 1H and 19F open coil imaging of arthritic rabbit knee at 3T.

Authors:  Franklin D Hockett; Kirk D Wallace; Anne H Schmieder; Shelton D Caruthers; Christine T N Pham; Samuel A Wickline; Gregory M Lanza
Journal:  IEEE Trans Med Imaging       Date:  2010-08-09       Impact factor: 10.048

6.  Simultaneous dual-nuclei imaging for motion corrected detection and quantification of 19F imaging agents.

Authors:  Jochen Keupp; Jürgen Rahmer; Ingmar Grässlin; Peter C Mazurkewitz; Tobias Schaeffter; Gregory M Lanza; Samuel A Wickline; Shelton D Caruthers
Journal:  Magn Reson Med       Date:  2011-03-09       Impact factor: 4.668

7.  Molecular imaging of angiogenesis in early-stage atherosclerosis with alpha(v)beta3-integrin-targeted nanoparticles.

Authors:  Patrick M Winter; Anne M Morawski; Shelton D Caruthers; Ralph W Fuhrhop; Huiying Zhang; Todd A Williams; John S Allen; Elizabeth K Lacy; J David Robertson; Gregory M Lanza; Samuel A Wickline
Journal:  Circulation       Date:  2003-10-13       Impact factor: 29.690

Review 8.  Coronary plaque erosion without rupture into a lipid core. A frequent cause of coronary thrombosis in sudden coronary death.

Authors:  A Farb; A P Burke; A L Tang; T Y Liang; P Mannan; J Smialek; R Virmani
Journal:  Circulation       Date:  1996-04-01       Impact factor: 29.690

Review 9.  The role of inflammation in venous thromboembolism and the link between arterial and venous thrombosis.

Authors:  P Poredos; M K Jezovnik
Journal:  Int Angiol       Date:  2007-12       Impact factor: 2.789

Review 10.  Endothelial dysfunction in the apolipoprotein E-deficient mouse: insights into the influence of diet, gender and aging.

Authors:  Silvana S Meyrelles; Veronica A Peotta; Thiago M C Pereira; Elisardo C Vasquez
Journal:  Lipids Health Dis       Date:  2011-11-14       Impact factor: 3.876

View more
  5 in total

1.  Quantification of vascular damage in acute kidney injury with fluorine magnetic resonance imaging and spectroscopy.

Authors:  Jeremy K Moore; Junjie Chen; Hua Pan; Joseph P Gaut; Sanjay Jain; Samuel A Wickline
Journal:  Magn Reson Med       Date:  2017-11-16       Impact factor: 4.668

Review 2.  The principles and applications of avidin-based nanoparticles in drug delivery and diagnosis.

Authors:  Akshay Jain; Kun Cheng
Journal:  J Control Release       Date:  2016-11-16       Impact factor: 9.776

3.  Inhibition of Thrombin With PPACK-Nanoparticles Restores Disrupted Endothelial Barriers and Attenuates Thrombotic Risk in Experimental Atherosclerosis.

Authors:  Rohun U Palekar; Andrew P Jallouk; Jacob W Myerson; Hua Pan; Samuel A Wickline
Journal:  Arterioscler Thromb Vasc Biol       Date:  2016-01-14       Impact factor: 8.311

Review 4.  The Multifaceted Uses and Therapeutic Advantages of Nanoparticles for Atherosclerosis Research.

Authors:  Nicholas DiStasio; Stephanie Lehoux; Ali Khademhosseini; Maryam Tabrizian
Journal:  Materials (Basel)       Date:  2018-05-08       Impact factor: 3.623

5.  Anti-JNK2 peptide-siRNA nanostructures improve plaque endothelium and reduce thrombotic risk in atherosclerotic mice.

Authors:  Hua Pan; Rohun U Palekar; Kirk K Hou; John Bacon; Huimin Yan; Luke E Springer; Antonina Akk; Lihua Yang; Mark J Miller; Christine Tn Pham; Paul H Schlesinger; Samuel A Wickline
Journal:  Int J Nanomedicine       Date:  2018-09-06
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.